Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments
NonrulemakingNoticeFDA-2026-N-0809-0001
Comments
0
Awaiting comments
Deadline
23 days
Closes Jul 14, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Mar 3, 2026
- Comment period
- Mar 3, 2026 – Jul 14, 2026
- Agency
- Food and Drug Administration (FDA)
- FR Doc
- 2026-04196
Analysis
Overview
No comments yet — comment period open · 23 days left.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.